Charakterisierung von Patienten mit Psoriasisarthritis in der dermatologischen und rheumatologischen Versorgung: Analyse von zwei Registern

Die Psoriasisarthritis (PsA) ist eine chronische systemische Entzündungskrankheit, die den Bewegungsapparat, die Haut und die Nägel betrifft. Ziel ist es, soziodemografische und klinische Patientenprofile zu charakterisieren, die in der dermatologischen und rheumatologischen Versorgung dokumentiert werden.

[1]  N. Mohr,et al.  Epidemiology of skin diseases in Germany: systematic review of the current state of research – part 1: cutaneous tumor diseases , 2022, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[2]  P. Elsner,et al.  Inpatient care for skin diseases in Germany: multi‐source analysis on the current and future health care needs , 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[3]  K. Reich,et al.  German S3‐Guideline on the treatment of Psoriasis vulgaris, adapted from EuroGuiDerm – Part 2: Treatment monitoring and specific clinical or comorbid situations , 2021, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[4]  L. Coates,et al.  Sex-specific differences and how to handle them in early psoriatic arthritis , 2021, Arthritis Research & Therapy.

[5]  A. Armstrong,et al.  Comparative Efficacy and Relative Ranking of Biologics and Oral Therapies for Moderate-to-Severe Plaque Psoriasis: A Network Meta-analysis , 2021, Dermatology and Therapy.

[6]  H. Alkan,et al.  Gender-Related Differences in Disease Activity and Clinical Features in Patients with Peripheral Psoriatic Arthritis: A Multi-Center Study. , 2021, Joint bone spine.

[7]  Georg Schett,et al.  Implementing an automated monitoring process in a digital, longitudinal observational cohort study , 2021, Arthritis Research & Therapy.

[8]  N. Mohr,et al.  Quality of psoriasis care in Germany – results from the nationwide health care studies PsoHealth 2004‐2017 , 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

[9]  W. Boehncke,et al.  LOOP, a cross-sectional, observational study investigating the clinical specialty setting as a determinant of disease management in psoriatic arthritis: Subgroup analysis results from Japan , 2021, PloS one.

[10]  L. Gossec,et al.  Gender differences in patient journey to diagnosis and disease outcomes: results from the European Map of Axial Spondyloarthritis (EMAS) , 2021, Clinical Rheumatology.

[11]  L. Bianchi,et al.  Management of psoriatic arthritis in rheumatology and dermatology settings: sub-analysis of the Italian population from the international LOOP study , 2020, Clinical Rheumatology.

[12]  J. Craig,et al.  Clinicians’ perspectives of shared care of psoriatic arthritis and psoriasis between rheumatology and dermatology: an interview study , 2020, Clinical Rheumatology.

[13]  H. Alkan,et al.  The effect of gender on disease activity and clinical characteristics in patients with axial psoriatic arthritis , 2020, Modern rheumatology.

[14]  J. Griffith,et al.  Effect of biologics on radiographic progression of peripheral joint in patients with psoriatic arthritis: meta-analysis. , 2020, Rheumatology.

[15]  W. Tillett,et al.  Disease Characteristics and the Burden of Joint and Skin Involvement Amongst People With Psoriatic Arthritis: A Population Survey , 2020, Rheumatology and Therapy.

[16]  J. Primdahl,et al.  EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update , 2020, Annals of the Rheumatic Diseases.

[17]  W. Boehncke,et al.  Association between clinical specialty setting and disease management in patients with psoriatic arthritis: results from LOOP, a cross‐sectional, multi‐country, observational study , 2020, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  B. Lockshin,et al.  Impact of Clinical Specialty Setting and Geographic Regions on Disease Management in Patients with Psoriatic Arthritis in the United States: A Multicenter Observational Study , 2019, American journal of clinical dermatology.

[19]  A. Armstrong,et al.  Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry , 2019, RMD Open.

[20]  A. Strangfeld,et al.  RABBIT-SpA: ein neues Krankheitsregister für axiale Spondyloarthritis und Psoriasisarthritis , 2019, Zeitschrift für Rheumatologie (Print).

[21]  Jasvinder A. Singh,et al.  2018 American College of Rheumatology/National Psoriasis Foundation Guideline for the Treatment of Psoriatic Arthritis , 2018, Arthritis care & research.

[22]  A. Gottlieb,et al.  Group for Research and Assessment of Psoriasis and Psoriatic Arthritis/Outcome Measures in Rheumatology Consensus‐Based Recommendations and Research Agenda for Use of Composite Measures and Treatment Targets in Psoriatic Arthritis , 2018, Arthritis & rheumatology.

[23]  M. Augustin,et al.  Incremental burden of cardiovascular comorbidity and psoriatic arthritis among adults with moderate‐to‐severe psoriasis in five European countries , 2017, Journal of the European Academy of Dermatology and Venereology : JEADV.

[24]  P. Gisondi,et al.  Impact of training on concordance among rheumatologists and dermatologists in the assessment of patients with psoriasis and psoriatic arthritis. , 2016, Seminars in arthritis and rheumatism.

[25]  A. Gottlieb,et al.  Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis , 2016, Arthritis & rheumatology.

[26]  Nico Wulffraat.  SP0010 INFECTIOUS RISK AND MANAGEMENT OF VACCINATION , 2017, Speaker Abstracts.

[27]  M. Augustin,et al.  Promoting patient‐centred care in psoriatic arthritis: a multidisciplinary European perspective on improving the patient experience , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  K. Reich,et al.  Drug safety of systemic treatments for psoriasis: results from The German Psoriasis Registry PsoBest , 2015, Archives of Dermatological Research.

[29]  T. Luger,et al.  German psoriasis registry PsoBest: objectives, methodology and baseline data , 2014, Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG.

[30]  D. Gladman,et al.  Prevalence of rheumatologist-diagnosed psoriatic arthritis in patients with psoriasis in European/North American dermatology clinics. , 2013, Journal of the American Academy of Dermatology.

[31]  N. Freemantle,et al.  Do men consult less than women? An analysis of routinely collected UK general practice data , 2013, BMJ Open.

[32]  D. Gladman,et al.  Gender difference in disease expression, radiographic damage and disability among patients with psoriatic arthritis , 2012, Annals of the rheumatic diseases.

[33]  K. Reich,et al.  Nail psoriasis as a severity indicator: results from the PsoReal study , 2010, Patient related outcome measures.

[34]  A. Gottlieb,et al.  International multicenter psoriasis and psoriatic arthritis reliability trial for the assessment of skin, joints, nails, and dactylitis. , 2009, Arthritis and rheumatism.

[35]  K. Reich,et al.  Prevalence and clinical features of psoriatic arthritis and joint complaints in 2009 patients with psoriasis: results of a German national survey , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[36]  K. Reich,et al.  Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1511 patients with plaque‐type psoriasis , 2009, The British journal of dermatology.

[37]  A. Gottlieb,et al.  Treatment recommendations for psoriatic arthritis , 2008, Annals of the rheumatic diseases.

[38]  K. Reich,et al.  Disease Severity, Quality of Life and Health Care in Plaque-Type Psoriasis: A Multicenter Cross-Sectional Study in Germany , 2008, Dermatology.

[39]  F. Cheater,et al.  Men and health help-seeking behaviour: literature review. , 2005, Journal of advanced nursing.

[40]  D. Gladman,et al.  Psoriatic arthritis: epidemiology, clinical features, course, and outcome , 2005, Annals of the rheumatic diseases.

[41]  A. Finlay,et al.  Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.

[42]  G. Stucki,et al.  Evaluation of a German version of the physical dimensions of the Health Assessment Questionnaire in patients with rheumatoid arthritis. , 1994, The Journal of rheumatology.